Intrinsic value of Nutrisystem - NTRI

Previous Close

$50.40

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$50.40

 
Intrinsic value

$145.31

 
Up/down potential

+188%

 
Rating

str. buy

 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of NTRI stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.5

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  17.71
  31.50
  28.85
  26.47
  24.32
  22.39
  20.65
  19.08
  17.67
  16.41
  15.27
  14.24
  13.32
  12.48
  11.74
  11.06
  10.46
  9.91
  9.42
  8.98
  8.58
  8.22
  7.90
  7.61
  7.35
  7.11
  6.90
  6.71
  6.54
  6.39
  6.25
Revenue, $m
  545
  717
  923
  1,168
  1,452
  1,777
  2,144
  2,553
  3,004
  3,497
  4,031
  4,605
  5,218
  5,869
  6,558
  7,284
  8,045
  8,843
  9,675
  10,544
  11,449
  12,390
  13,369
  14,386
  15,443
  16,542
  17,684
  18,871
  20,105
  21,389
  22,725
Variable operating expenses, $m
 
  594
  766
  968
  1,204
  1,473
  1,777
  2,116
  2,490
  2,899
  3,341
  3,817
  4,326
  4,866
  5,437
  6,038
  6,669
  7,330
  8,021
  8,741
  9,491
  10,271
  11,083
  11,926
  12,802
  13,713
  14,660
  15,644
  16,667
  17,731
  18,839
Fixed operating expenses, $m
 
  41
  42
  43
  44
  45
  46
  48
  49
  50
  51
  52
  54
  55
  57
  58
  59
  61
  62
  64
  66
  67
  69
  71
  72
  74
  76
  78
  80
  82
  84
Total operating expenses, $m
  491
  635
  808
  1,011
  1,248
  1,518
  1,823
  2,164
  2,539
  2,949
  3,392
  3,869
  4,380
  4,921
  5,494
  6,096
  6,728
  7,391
  8,083
  8,805
  9,557
  10,338
  11,152
  11,997
  12,874
  13,787
  14,736
  15,722
  16,747
  17,813
  18,923
Operating income, $m
  54
  82
  116
  157
  204
  259
  320
  389
  465
  548
  638
  735
  838
  949
  1,065
  1,188
  1,316
  1,451
  1,592
  1,739
  1,892
  2,052
  2,217
  2,389
  2,568
  2,754
  2,948
  3,149
  3,358
  3,576
  3,802
EBITDA, $m
  68
  89
  126
  169
  220
  278
  344
  417
  498
  586
  682
  786
  896
  1,013
  1,137
  1,268
  1,405
  1,548
  1,699
  1,855
  2,018
  2,188
  2,364
  2,548
  2,738
  2,936
  3,142
  3,357
  3,579
  3,811
  4,052
Interest expense (income), $m
  0
  0
  1
  1
  2
  3
  5
  6
  8
  9
  11
  13
  15
  18
  20
  23
  26
  28
  31
  35
  38
  41
  45
  49
  52
  56
  61
  65
  69
  74
  79
Earnings before tax, $m
  54
  82
  115
  155
  202
  255
  316
  383
  457
  539
  627
  722
  823
  931
  1,045
  1,165
  1,291
  1,423
  1,561
  1,704
  1,854
  2,010
  2,172
  2,341
  2,516
  2,698
  2,887
  3,084
  3,289
  3,501
  3,723
Tax expense, $m
  19
  22
  31
  42
  54
  69
  85
  103
  123
  145
  169
  195
  222
  251
  282
  314
  349
  384
  421
  460
  501
  543
  587
  632
  679
  728
  780
  833
  888
  945
  1,005
Net income, $m
  35
  60
  84
  113
  147
  186
  230
  280
  334
  393
  458
  527
  601
  679
  763
  850
  942
  1,039
  1,139
  1,244
  1,354
  1,467
  1,586
  1,709
  1,837
  1,970
  2,108
  2,251
  2,401
  2,556
  2,718

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  34
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  154
  158
  203
  257
  320
  391
  472
  562
  661
  770
  887
  1,014
  1,149
  1,292
  1,444
  1,604
  1,771
  1,947
  2,130
  2,321
  2,521
  2,728
  2,943
  3,167
  3,400
  3,642
  3,893
  4,155
  4,426
  4,709
  5,003
Adjusted assets (=assets-cash), $m
  120
  158
  203
  257
  320
  391
  472
  562
  661
  770
  887
  1,014
  1,149
  1,292
  1,444
  1,604
  1,771
  1,947
  2,130
  2,321
  2,521
  2,728
  2,943
  3,167
  3,400
  3,642
  3,893
  4,155
  4,426
  4,709
  5,003
Revenue / Adjusted assets
  4.542
  4.538
  4.547
  4.545
  4.538
  4.545
  4.542
  4.543
  4.545
  4.542
  4.545
  4.541
  4.541
  4.543
  4.542
  4.541
  4.543
  4.542
  4.542
  4.543
  4.541
  4.542
  4.543
  4.542
  4.542
  4.542
  4.543
  4.542
  4.542
  4.542
  4.542
Average production assets, $m
  30
  39
  51
  64
  80
  98
  118
  140
  165
  192
  222
  253
  287
  323
  361
  401
  442
  486
  532
  580
  630
  681
  735
  791
  849
  910
  973
  1,038
  1,106
  1,176
  1,250
Working capital, $m
  42
  11
  14
  18
  22
  27
  32
  38
  45
  52
  60
  69
  78
  88
  98
  109
  121
  133
  145
  158
  172
  186
  201
  216
  232
  248
  265
  283
  302
  321
  341
Total debt, $m
  0
  19
  41
  68
  98
  133
  173
  218
  266
  320
  378
  440
  506
  577
  651
  730
  812
  899
  989
  1,083
  1,181
  1,283
  1,389
  1,499
  1,614
  1,733
  1,857
  1,985
  2,119
  2,258
  2,403
Total liabilities, $m
  60
  78
  100
  127
  157
  192
  232
  277
  325
  379
  437
  499
  565
  636
  710
  789
  871
  958
  1,048
  1,142
  1,240
  1,342
  1,448
  1,558
  1,673
  1,792
  1,916
  2,044
  2,178
  2,317
  2,462
Total equity, $m
  95
  80
  103
  131
  162
  199
  240
  286
  336
  391
  451
  515
  584
  656
  733
  815
  900
  989
  1,082
  1,179
  1,280
  1,386
  1,495
  1,609
  1,727
  1,850
  1,978
  2,111
  2,249
  2,392
  2,542
Total liabilities and equity, $m
  155
  158
  203
  258
  319
  391
  472
  563
  661
  770
  888
  1,014
  1,149
  1,292
  1,443
  1,604
  1,771
  1,947
  2,130
  2,321
  2,520
  2,728
  2,943
  3,167
  3,400
  3,642
  3,894
  4,155
  4,427
  4,709
  5,004
Debt-to-equity ratio
  0.000
  0.230
  0.400
  0.520
  0.610
  0.670
  0.720
  0.760
  0.790
  0.820
  0.840
  0.850
  0.870
  0.880
  0.890
  0.900
  0.900
  0.910
  0.910
  0.920
  0.920
  0.930
  0.930
  0.930
  0.930
  0.940
  0.940
  0.940
  0.940
  0.940
  0.950
Adjusted equity ratio
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  35
  60
  84
  113
  147
  186
  230
  280
  334
  393
  458
  527
  601
  679
  763
  850
  942
  1,039
  1,139
  1,244
  1,354
  1,467
  1,586
  1,709
  1,837
  1,970
  2,108
  2,251
  2,401
  2,556
  2,718
Depreciation, amort., depletion, $m
  14
  8
  10
  13
  16
  20
  24
  28
  33
  38
  44
  51
  57
  65
  72
  80
  88
  97
  106
  116
  126
  136
  147
  158
  170
  182
  195
  208
  221
  235
  250
Funds from operations, $m
  45
  67
  94
  126
  163
  206
  254
  308
  367
  432
  502
  577
  658
  744
  835
  930
  1,031
  1,136
  1,246
  1,360
  1,480
  1,604
  1,733
  1,867
  2,007
  2,152
  2,302
  2,459
  2,622
  2,791
  2,968
Change in working capital, $m
  -6
  3
  3
  4
  4
  5
  6
  6
  7
  7
  8
  9
  9
  10
  10
  11
  11
  12
  12
  13
  14
  14
  15
  15
  16
  16
  17
  18
  19
  19
  20
Cash from operations, $m
  51
  49
  91
  122
  159
  201
  248
  301
  360
  424
  494
  569
  649
  734
  824
  920
  1,019
  1,124
  1,233
  1,347
  1,466
  1,590
  1,718
  1,852
  1,991
  2,135
  2,285
  2,441
  2,603
  2,772
  2,948
Maintenance CAPEX, $m
  0
  -6
  -8
  -10
  -13
  -16
  -20
  -24
  -28
  -33
  -38
  -44
  -51
  -57
  -65
  -72
  -80
  -88
  -97
  -106
  -116
  -126
  -136
  -147
  -158
  -170
  -182
  -195
  -208
  -221
  -235
New CAPEX, $m
  -15
  -9
  -11
  -13
  -16
  -18
  -20
  -22
  -25
  -27
  -29
  -32
  -34
  -36
  -38
  -40
  -42
  -44
  -46
  -48
  -50
  -52
  -54
  -56
  -58
  -60
  -63
  -65
  -68
  -71
  -74
Cash from investing activities, $m
  -29
  -15
  -19
  -23
  -29
  -34
  -40
  -46
  -53
  -60
  -67
  -76
  -85
  -93
  -103
  -112
  -122
  -132
  -143
  -154
  -166
  -178
  -190
  -203
  -216
  -230
  -245
  -260
  -276
  -292
  -309
Free cash flow, $m
  22
  33
  72
  99
  131
  167
  209
  255
  307
  364
  426
  493
  565
  641
  722
  807
  897
  992
  1,090
  1,193
  1,300
  1,412
  1,528
  1,649
  1,774
  1,905
  2,040
  2,181
  2,328
  2,480
  2,639
Issuance/(repayment) of debt, $m
  0
  19
  22
  26
  31
  35
  40
  44
  49
  53
  58
  62
  66
  71
  75
  79
  82
  86
  90
  94
  98
  102
  106
  110
  115
  119
  124
  129
  134
  139
  145
Issuance/(repurchase) of shares, $m
  3
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  3
  19
  22
  26
  31
  35
  40
  44
  49
  53
  58
  62
  66
  71
  75
  79
  82
  86
  90
  94
  98
  102
  106
  110
  115
  119
  124
  129
  134
  139
  145
Total cash flow (excl. dividends), $m
  24
  52
  94
  125
  161
  202
  248
  300
  356
  418
  484
  555
  631
  712
  797
  886
  980
  1,078
  1,180
  1,287
  1,398
  1,514
  1,634
  1,759
  1,889
  2,024
  2,164
  2,310
  2,462
  2,619
  2,784
Retained Cash Flow (-), $m
  -25
  -19
  -23
  -27
  -32
  -36
  -41
  -46
  -50
  -55
  -60
  -64
  -69
  -73
  -77
  -81
  -85
  -89
  -93
  -97
  -101
  -105
  -109
  -114
  -118
  -123
  -128
  -133
  -138
  -144
  -149
Prev. year cash balance distribution, $m
 
  34
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  67
  71
  98
  130
  166
  207
  254
  306
  362
  424
  491
  563
  639
  720
  805
  895
  989
  1,087
  1,190
  1,297
  1,409
  1,525
  1,645
  1,771
  1,901
  2,036
  2,177
  2,324
  2,476
  2,634
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  64
  65
  85
  107
  129
  151
  172
  191
  208
  222
  233
  240
  243
  242
  236
  227
  215
  200
  183
  165
  146
  126
  108
  90
  74
  59
  47
  36
  27
  20
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Nutrisystem, Inc., together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers Nutrisystem program that consists of approximately 150 portion-controlled items, which serve as the foundation of a low glycemic index diet. Its programs comprise Nutrisystem D, a program designed for people with type 2 diabetes for losing weight and managing their diabetes; Turbo10 program, a program that deliver up to a 10-pound weight loss and a reduction of 5 inches overall in the first month of dieting; and 5-day kit, a kit for individuals with or at risk of type 2 diabetes, as well as SmartCarb and PowerFuel products, including blueberry muffins, cinnamon buns, vanilla shakes, chocolate shakes, and chocolate chip cookie packs. The company also provides My Daily 3, a physical activity program, which provides information on diet, nutrition, and physical activity; and NuMi, a digital product that integrates with wearable fitness devices and health platforms. It offers monthly food packages of frozen and ready-to-go food containing four-week meal plan of breakfasts, lunches, dinners, and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables, and dairy. The company sells its pre-packaged foods to weight loss program participants directly through the Internet and telephone; a television shopping network; and retailers. Nutrisystem, Inc. was founded in 1972 and is based in Fort Washington, Pennsylvania.

FINANCIAL RATIOS  of  Nutrisystem (NTRI)

Valuation Ratios
P/E Ratio 42.8
Price to Sales 2.7
Price to Book 15.8
Price to Tangible Book
Price to Cash Flow 29.3
Price to Free Cash Flow 41.6
Growth Rates
Sales Growth Rate 17.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 15.4%
Cap. Spend. - 3 Yr. Gr. Rate 13.4%
Financial Strength
Quick Ratio NaN
Current Ratio 0.2
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 24.6%
Ret/ On Assets - 3 Yr. Avg. 21.4%
Return On Total Capital 42.4%
Ret/ On T. Cap. - 3 Yr. Avg. 39.6%
Return On Equity 42.4%
Return On Equity - 3 Yr. Avg. 39.6%
Asset Turnover 3.8
Profitability Ratios
Gross Margin 52.8%
Gross Margin - 3 Yr. Avg. 51.6%
EBITDA Margin 12.5%
EBITDA Margin - 3 Yr. Avg. 10.7%
Operating Margin 9.9%
Oper. Margin - 3 Yr. Avg. 8.6%
Pre-Tax Margin 9.9%
Pre-Tax Margin - 3 Yr. Avg. 8.6%
Net Profit Margin 6.4%
Net Profit Margin - 3 Yr. Avg. 5.6%
Effective Tax Rate 35.2%
Eff/ Tax Rate - 3 Yr. Avg. 34.9%
Payout Ratio 60%

NTRI stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the NTRI stock intrinsic value calculation we used $545 million for the last fiscal year's total revenue generated by Nutrisystem. The default revenue input number comes from 2016 income statement of Nutrisystem. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our NTRI stock valuation model: a) initial revenue growth rate of 31.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for NTRI is calculated based on our internal credit rating of Nutrisystem, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Nutrisystem.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of NTRI stock the variable cost ratio is equal to 82.9%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $40 million in the base year in the intrinsic value calculation for NTRI stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Nutrisystem.

Corporate tax rate of 27% is the nominal tax rate for Nutrisystem. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the NTRI stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for NTRI are equal to 5.5%.

Life of production assets of 2.1 years is the average useful life of capital assets used in Nutrisystem operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for NTRI is equal to 1.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $95 million for Nutrisystem - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 29.96 million for Nutrisystem is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Nutrisystem at the current share price and the inputted number of shares is $1.5 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
WTW Weight Watcher 27.17 prem.  prem.
MED Medifast 41.55 prem.  prem.
RGS Regis 9.20 prem.  prem.
AMZN Amazon.com 993.38 prem.  prem.
QVCA Liberty Intera 23.72 prem.  prem.
WMT Wal-Mart Store 78.31 prem.  prem.
SFLY Shutterfly 50.49 prem.  prem.

COMPANY NEWS

▶ ETFs with exposure to Nutrisystem, Inc. : May 16, 2017   [May-16-17 12:57PM  Capital Cube]
▶ Which Companies Are Now Outperforming 95% Of All Stocks?   [May-09-17 12:21PM  Investor's Business Daily]
▶ Dow Industrials, Apple Cut Losses; Should You Sell These 4 Big Stock Winners?   [May-03-17 01:41PM  Investor's Business Daily]
▶ Dow Industrials Up 1.9% For The Week; Will Snap Give A Buy Point Soon?   [Apr-28-17 06:30PM  Investor's Business Daily]
▶ Nutrisystem beats Street 1Q forecasts   [05:06PM  Associated Press]
▶ The Skinny On A Top Stock: Nutrisystem Looks Ripped This Diet Season   [Apr-24-17 04:25PM  Investor's Business Daily]
▶ Is it Do or Die for Brands on Instagram?   [Apr-07-17 02:53PM  Zacks]
▶ Top Ranked Momentum Stocks to Buy for April 5th   [Apr-05-17 09:17AM  Zacks]
▶ 3 Hot Health & Fitness Stocks for 2017   [Apr-03-17 11:43AM  Motley Fool]
▶ 3 Hot Health & Fitness Stocks for 2017   [11:43AM  at Motley Fool]
▶ Why NutriSystem Inc. Stock Jumped   [12:59PM  at Motley Fool]
▶ Nutrisystem, Inc. Announces Multi-Brand Approach for 2017   [Dec-27-16 09:01AM  Business Wire]
▶ Is New Mountain Finance Corp. (NMFC) A Good Stock To Buy?   [Dec-12-16 12:34PM  at Insider Monkey]
▶ NutriSystem Inc. (NTRI): Hedge Funds Holdings Are Losing Weight   [Nov-28-16 10:16PM  at Insider Monkey]
Stock chart of NTRI Financial statements of NTRI Annual reports of NTRI
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.